Microsoft loses No. 2 ranking in market value to drug maker
Microsoft has lost its status as the world’s second-largest corporation to drug maker Pfizer due to slowing sales growth that caused it to miss out on this year’s stock-market rally.
Report Says More Farmers Don’t Follow Biotech Rules
A new study, drawn from government data, shows that more farmers are failing to comply with standards governing the planting of genetically modified corn than the industry has claimed.
Nearly one-fifth of farms growing the main type of genetically engineered corn, BT corn, are violating government rules aimed at preserving the usefulness of the corn, a consumer group said yesterday.
More regulations for biotech products aren’t necessary, FDA says
Genetically engineered foods from crops that have already been reviewed and approved by two government agencies shouldn’t have to jump through a third regulatory hoop at the Food and Drug Administration, an FDA official told Congress Tuesday.
Pfizer unveils anti-smoking drug
Pfizer Inc. introduced a new anti-smoking drug Tuesday that could become one of its biggest selling products.
New Drug Rules Aim To Speed Generics
President Bush today announced new regulations to hasten the pace at which generic drugs are brought to market, a measure the administration says will save $3.5 billion annually after it takes effect Aug. 18.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Recent Comments